NPI registry status
Active
2026 NPPES data Hematology & Oncology Physician NPI 1417908211 MD
Verify on CMS → Meredith Selleck, MD
Hematology & Oncology Physician in Concord, New Hampshire.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 11,530 in Hematology & Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
331
Medicare Part D claims · 122 beneficiaries · Hematology & Oncology Physician avg: 885
Generic prescribing
92%
generic claims · 8% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$104.71
2 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Meredith Selleck, MD filed 331 Medicare Part D claims in 2024 as a Hematology & Oncology Physician in Concord, New Hampshire, prescribing 92% generic.
- 331
- Part D claims, 2024
- 92%
- generic prescribing
- Likely
- board-certified (heuristic)
- ≥56th
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Meredith Selleck, MD
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1417908211), first enumerated 05/15/2006.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 331 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
3 CMS Care Compare hospital affiliations on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Reported
Industry payment transparency
$104.71 in reported industry payments (2 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1417908211 · Hematology & Oncology Physician
NPI-10 · ENUM-LEGACY · TAX-MID · RX-LIGHT · BOOK-THIN · PHOTO-ENUM
- NPI-10 1417908211
- ENUM-LEGACY 2006
- TAX-MID 12K Hematology &
- RX-LIGHT 331
- BOOK-THIN 63 in New Hampshire
- PHOTO-ENUM Sara Booth, CPNP · 2006
Meredith Selleck, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
331 ≥ 56th percentile 56% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
✓
Board certification likely (heuristic, not verified)
Meredith Selleck, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 3 hospital affiliations - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Meredith Selleck, MD?
Quality data not reportedPrimary specialty
Hematology & Oncology Physician
Medicare Part D claims
331 63% vs specialty avg
Specialty distribution in New Hampshire
How Hematology & Oncology Physician compares to other specialties among New Hampshire providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Hematology & Oncology Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1417908211 |
|---|---|
| Specialty | Hematology & Oncology Physician |
| Credentials | MD |
| Gender | Female |
| NPI Issued | 05/15/2006 |
Hospital and facility affiliations
Facilities where Meredith Selleck, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
According to CMS billing records, Meredith Selleck, MD is affiliated with 3 Medicare-billing facilities.
Dana-Farber Cancer Institute, Inc.
Londonderry, NH
Elliot Professional Services
Manchester, NH
New Hampshire Oncology-Hematology PA
Concord, NH
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Meredith Selleck, MD. Source: openpaymentsdata.cms.gov.
Total received
$105
Largest payer
ImmunoGen, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Generic-heavy
Meredith Selleck, MD - brand share 8.0%
Hematology & Oncology Physician average
8% brand-name claims vs 92% generic, on 331 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
331
Total Claims
$170K
Total Drug Cost
122
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 501.033
- Total Day Supply
- 12,964
- Brand vs Generic
- 8% brand / 92% generic
- Brand Drug Cost
- $162K
- Generic Drug Cost
- $8K
Patient Demographics
- Average Patient Age
- 73.0 years
- Avg HCC Risk Score
- 1.86
- Gender Split
- 73% female / 27% male
- Age Distribution
- <65: 11, 65-74: 62, 75-84: N/A, 85+: N/A
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Meredith Selleck, MD prescribes most
Top Medicare Part D drugs by claim count, 2024
- Anastrozole
Anastrozole
46 claims
- Dexamethasone
Dexamethasone
42 claims
- Letrozole
Letrozole
26 claims
- Prednisone
Prednisone
22 claims
- Olanzapine
Olanzapine
21 claims
- Tamoxifen Citrate 18
Tamoxifen Citrate
18 claims
| Drug | Claims |
|---|---|
| Anastrozole | 46 |
| Dexamethasone | 42 |
| Letrozole | 26 |
| Prednisone | 22 |
| Olanzapine | 21 |
| Tamoxifen Citrate | 18 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Hematology & Oncology Physician Overview
How Meredith Selleck, MD fits within the Hematology & Oncology Physician landscape nationally.
11,530
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
885
Avg Claims per Provider
Meredith Selleck, MD's 331 claims are below the specialty average of 885.
Nationwide Hematology & Oncology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Selleck, both outside New Hampshire so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Hematology & Oncology Physician Providers in New Hampshire
Other clinicians with the same primary specialty enrolled in New Hampshire, drawn from the same CMS NPPES roster as Selleck.
One of 63 Hematology & Oncology Physician providers enrolled in New Hampshire, 5 are shown here.
Dr. Elizabeth Bengtson
MD
Lebanon, NH
Dr. Amy Bessnow
MD
Dover, NH
Dr. Archana Bhargava
MD
Dover, NH
Dr. Eric Bonnem
MD
Manchester, NH
Dr. Frederick Briccetti
MD
Concord, NH
Compare Hematology & Oncology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Meredith Selleck, MD's specialty? ▼
Meredith Selleck, MD specializes in Hematology & Oncology Physician and practices in Concord, New Hampshire. Credentials: MD.
How much does Meredith Selleck, MD prescribe under Medicare Part D? ▼
In 2024, Meredith Selleck, MD wrote 331 Medicare Part D claims totaling $170K in drug costs for 122 beneficiaries.
Where is Meredith Selleck, MD located? ▼
Meredith Selleck, MD is located at 250 PLEASANT ST, Concord, NH, 03301. Phone: (036) 226-4846.
What is Meredith Selleck, MD's NPI number? ▼
Meredith Selleck, MD's National Provider Identifier (NPI) is 1417908211, issued on 05/15/2006.
Does Meredith Selleck, MD prescribe more brand-name or generic drugs? ▼
Meredith Selleck, MD's prescribing is 8% brand-name and 92% generic drugs by claim count, with $162K in brand drug costs.
How many Hematology & Oncology Physician providers are there in the US? ▼
There are 11,530 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 885 Medicare Part D claims per year.
What drugs does Meredith Selleck, MD prescribe most often? ▼
Based on 2024 Medicare Part D data, Meredith Selleck, MD's most frequently prescribed drugs include Anastrozole, Dexamethasone, Letrozole. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Meredith Selleck, MD accept Medicare? ▼
Meredith Selleck, MD appears in CMS Medicare data with 331 Part D claims and 122 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Meredith Selleck, MD's credentials? ▼
Meredith Selleck, MD's NPI is 1417908211 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.